SofWave Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	8.85	5.49	-4.55	-8.28	-19.53	-6.83
Depreciation & Amortization	2.08	1.81	1.79	1.51	1.12	0.36
Loss (Gain) From Sale of Investments	0.27	-0.17	-	-	-	-
Stock-Based Compensation	1.71	2.32	2.4	2.28	5.14	5.04
Other Operating Activities	-1.24	-1.07	-0.29	-0.71	2.2	-2.27
Change in Accounts Receivable	-1.76	1.05	-0.84	-3.32	0.72	-4.85
Change in Inventory	-1.18	-0.34	-2.11	-1.62	-3.06	-1.9
Change in Accounts Payable	2.44	0.94	0.85	2.79	-2.45	4.92
Change in Other Net Operating Assets	2.67	3.27	0.35	1.05	5.17	1.13
Operating Cash Flow	13.85	13.3	-2.4	-6.31	-10.69	-4.4
Operating Cash Flow Growth	385.35%	-	-	-	-	-
Capital Expenditures	-0.78	-0.53	-0.28	-0.41	-0.45	-0.82
Investment in Securities	-10.11	-0.52	-	-	-	-
Other Investing Activities	1	0.64	0.53	0.82	0.19	-0.13
Investing Cash Flow	-9.9	-0.42	0.25	0.41	-0.26	-0.95
Long-Term Debt Repaid	-	-0.81	-0.66	-0.65	-0.69	-0.21
Net Debt Issued (Repaid)	-0.87	-0.81	-0.66	-0.65	-0.69	-0.21
Issuance of Common Stock	0.9	0.38	0.33	0	0.03	46.96
Other Financing Activities	-	-	-0.28	-1.08	-0.69	-0.1
Financing Cash Flow	0.04	-0.43	-0.62	-1.72	-1.35	46.64
Foreign Exchange Rate Adjustments	0.75	0.69	-0.04	0.04	-1.9	2.27
Net Cash Flow	4.75	13.13	-2.81	-7.58	-14.2	43.57
Free Cash Flow	13.07	12.76	-2.67	-6.71	-11.14	-5.22
Free Cash Flow Growth	402.58%	-	-	-	-	-
Free Cash Flow Margin	12.53%	14.56%	-4.48%	-13.34%	-31.27%	-23.90%
Free Cash Flow Per Share	0.33	0.32	-0.08	-0.20	-0.33	-0.22
Levered Free Cash Flow	12.7	13.3	0.84	-3.04	-4.75	-1.04
Unlevered Free Cash Flow	12.79	13.34	0.87	-3	-4.63	-0.97
Cash Income Tax Paid	0.19	0.19	0.24	-	-	-
Change in Working Capital	2.17	4.92	-1.75	-1.11	0.38	-0.7